Position in DERM
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$58,301
New position
Shares Held
12,431
first reported quarter
Ownership
0.045%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MetLife Investment Management, LLC holds $88,544,808 across 37 Drug Manufacturers - Specialty & Generic names. DERM ranks #35 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
|
304,172 | $15,722,650 | |
| 2 | ZTS |
Zoetis Inc.
|
114,814 | $13,572,162 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
21,171 | $12,553,979 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
53,053 | $6,989,202 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
244,343 | $5,847,127 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
67,088 | $5,088,624 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
211,317 | $4,386,940 | |
| 8 | VTRS |
Viatris Inc
|
269,168 | $3,636,459 |
All Filings in DERM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $58,301 | 12,431 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||